CLINICAL_TRIALS
trial_result
· 2013-12-10
Clinical Trial Update: D-serine Monotherapy for Schizophrenia [Phase 2]
Summary
A Phase 2 trial evaluating D-serine as monotherapy for schizophrenia has completed, sponsored by Herzog Hospital.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Herzog Hospital | Conditions: Schizophrenia | Phase 2 | Status: COMPLETED